Baxter International
| Type | Public |
| HQ | Deerfield, US |
| Founded | 1931 |
| Size (employees) | 47,000 (est)-2% |
| Website | baxter.com |
Baxter International was founded in 1931 and is headquartered in Deerfield, US
Report incorrect company information
Viewing summary data as a guest
Sign up for free to see all dataKey People/Management at Baxter International
Jose Almeida
Chairman, President and Chief Executive Officer
John Forsyth
Chairman and Chief Executive Officer, Wellmark Blue Cross and Blue Shield
James Gavin
Chief Executive Officer and Chief Medical Officer, Healing Our Village, Inc
Munib Islam
Partner and Head of Equities Research, Third Point LLC
Michael Mahoney
Chairman, President and Chief Executive Officer, Boston Scientific Corporation
Cathy Smith
Executive Vice President and Chief Financial Officer, Target Corporation
Report incorrect company information
Baxter International Office Locations
Baxter International has offices in Lombard, Houston, Baltimore, Bloomington and in 34 other locations
Deerfield, US (HQ)
One Baxter Parkway
Report incorrect company information
Baxter International Financials and Metrics
Baxter International Revenue
Baxter International's revenue was reported to be $10.16 b in FY, 2016 which is a 2% increase from the previous period.
| USD | |
|---|---|
Revenue (Q2, 2018) | 5.5 b |
Gross profit (Q2, 2018) | 2.4 b |
Gross profit margin (Q2, 2018), % | 42.6% |
Net income (Q2, 2018) | 732 m |
EBIT (Q2, 2018) | 816 m |
Market capitalization (20-Sep-2018) | 41.5 b |
Closing stock price (20-Sep-2018) | 77.7 |
Cash (30-Jun-2018) | 2.9 b |
Baxter International's current market capitalization is $41.5 b.
Annual
| USD | FY, 2015 | FY, 2016 |
|---|---|---|
Revenue | 10 b | 10.2 b |
Revenue growth, % | (40%) | 2% |
Cost of goods sold | 5.8 b | 6.1 b |
Gross profit | 4.1 b | 4.1 b |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.8 b | 4 b | 4.3 b | 4.2 b | 3.8 b | 3.9 b | 2.5 b | 2.4 b | 2.6 b | 2.6 b | 2.5 b | 2.6 b | 2.7 b | 5.5 b |
Cost of goods sold | 1.8 b | 2 b | 2.2 b | 2.1 b | 2 b | 2 b | 1.5 b | 1.4 b | 1.6 b | 1.5 b | 1.4 b | 1.5 b | 1.6 b | 3.2 b |
Gross profit | 1.9 b | 2 b | 2 b | 2.1 b | 1.8 b | 1.9 b | 1 b | 965 m | 972 m | 1.1 b | 1 b | 1.1 b | 1.1 b | 2.4 b |
Gross profit Margin, % | 52% | 50% | 48% | 49% | 48% | 49% | 42% | 41% | 38% | 42% | 42% | 43% | 42% | 43% |
Annual
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 2.7 b | 2.9 b | 2.2 b | 2.8 b |
Inventories | 3.5 b | 3.6 b | 1.6 b | 1.4 b |
Current Assets | 10 b | 10.4 b | 11.8 b | 6.6 b |
PP&E | 7.8 b | 8.7 b | 4.4 b | 4.3 b |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 2.4 b | 2 b | 1.9 b | 2.1 b | 2.5 b | 6.7 b | 2 b | 2.2 b | 2.6 b | 2.6 b | 2.9 b | 3.8 b | 2.9 b | 2.9 b |
Inventories | 3.6 b | 3.7 b | 3.8 b | 3.7 b | 3.5 b | 3.8 b | 1.7 b | 1.7 b | 1.6 b | 1.6 b | 1.5 b | 1.5 b | 1.6 b | 1.6 b |
Current Assets | 9.6 b | 9.4 b | 9.5 b | 9.6 b | 9.7 b | 14.5 b | 11.1 b | 8 b | 6.8 b | 6.6 b | 6.6 b | 7.7 b | 7 b | 6.9 b |
PP&E | 7.5 b | 8 b | 8.2 b | 8.4 b | 8.5 b | 9 b | 4.3 b | 4.4 b | 4.3 b | 4.3 b | 4.3 b | 4.3 b | 4.6 b | 4.5 b |
Annual
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 2 b | 2.5 b | 968 m | 5 b |
Inventories | (311 m) | (439 m) | 1.6 b | 80 m |
Cash From Operating Activities | 2.2 b | 3.2 b | 1.8 b | 1.7 b |
Cash From Investing Activities | 5.4 b | (1.5 b) | (1.8 b) | (715 m) |
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 544 m | 556 m | 520 m | 468 m | 430 m | 762 m | 763 m | 3.4 b | 4.6 b | 4.7 b | 272 m | 537 m | 389 m | 732 m |
Depreciation and Amortization | 497 m | 593 m | 189 m | 395 m | 599 m | 194 m | 378 m | 192 m | 387 m | |||||
Inventories | (439 m) | (205 m) | (26 m) | (25 m) | (11 m) | (29 m) | (38 m) | (56 m) | (134 m) | |||||
Accounts Payable | (103 m) | (109 m) |
| USD | Y, 2018 |
|---|---|
Financial Leverage | 1.9 x |
Report incorrect company information
Baxter International Online and Social Media Presence
12.89k Twitter followers
Baxter International has 12.89k Twitter Followers. The number of followers has increased 0.8% month over month and increased 0.6% quarter over quarter
8.38k Facebook likes
Baxter International has 8.38k Facebook Likes. The number of likes has increased 5.5% month over month and increased 11.8% quarter over quarter
Report incorrect company information
Baxter International News and Updates
August 31, 2018
Global Nephrology and Urology Devices Market Analysis & Forecasts, 2018-2024: Key Players are Baxter International, Fresenius Medical Care, Boston Scientific & C.R. Bard
DUBLIN, Aug 31, 2018 /PRNewswire/ -- The "Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024" report has been added to...
August 21, 2018
Tissue Sealants Global Market 2018: Key Players – 3M Company, Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., C. R. Bard, Inc.
Tissue Sealants -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday
August 21, 2018
Stem Cell Research in Cardiology Global Market 2018: Key Players – Athersys, Inc., Axordia Ltd, Baxter International, U.S. Stem Cell, Inc, Vericel Corporation
Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday
August 21, 2018
Stem Cell Research in Cardiology Global Market 2018: Key Players – Athersys, Inc., Axordia Ltd, Baxter International, U.S. Stem Cell, Inc, Vericel Corporation
Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday
May 04, 2018
Plasma Protein Therapeutics Market Overview, Analysis, Major Manufacturers, Production Price, Cost, Revenue & Market Status 2018 to 2023, focusing on Top Key Vendors like: : Baxter International, Biotest?, CSL Behring, China Biologics, GRIFOLS
The Global Plasma Protein Therapeutics Market Report includes a comprehensive analysis of the present market. The report starts with the basic Plasma Protein Therapeutics Market overview and then goes into each and every detail. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information
Baxter International Company Life and Culture
Report incorrect company information